Drinking from the firehose - A clinician's perspective on the challenges of delivering biomarker-driven care in routine practice

Eur J Cancer. 2021 Nov:157:301-305. doi: 10.1016/j.ejca.2021.08.037. Epub 2021 Sep 20.

Abstract

Countless biomarkers continue to be identified and analysed in the modern era of omics focused research, with innumerable articles purporting clinical utility and bolstering optimism for truly personalised cancer care. While many commentaries have expounded on the complexities of biomarker development, validation and reporting, the monumental challenge of integrating this research into clinical practice has to date received little attention. The challenges are multitude; variable and sometimes contradictory findings across studies for individual biomarkers, a rapidly evolving landscape with new biomarkers continually being presented and tendency to examine each biomarker in isolation. Here, using examples from colorectal cancer, we explore the difficulties for the practicing clinician in interpreting and integrating novel biomarkers. Here, we present the '4Cs' to interrogate the biomarker literature, including analysis of the credibility, consistency, completeness and context of the biomarker research, and suggest a framework to frame the literature moving forward.

Keywords: Biomarkers; Clinical utility; Colorectal cancer.

MeSH terms

  • Biomarkers, Tumor / analysis*
  • Biomedical Research / statistics & numerical data*
  • Colorectal Neoplasms / diagnosis
  • Colorectal Neoplasms / therapy*
  • Data Accuracy
  • Delivery of Health Care, Integrated / statistics & numerical data*
  • Delivery of Health Care, Integrated / trends
  • Humans
  • Practice Patterns, Physicians' / statistics & numerical data*
  • Practice Patterns, Physicians' / trends

Substances

  • Biomarkers, Tumor